Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | 12-1997 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,470 | -5,760 | -17,380 | N/A | N/A |
| Depreciation Amortization | 130 | 110 | 80 | N/A | N/A |
| Other Working Capital | 1,300 | -20 | 800 | N/A | N/A |
| Other Operating Activity | -20 | 30 | 360 | 0 | 0 |
| Operating Cash Flow | $-8,060 | $-5,640 | $-16,140 | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -200 | -80 | -130 | N/A | N/A |
| Other Investing Activity | 240 | 410 | 10 | 0 | 0 |
| Investing Cash Flow | $40 | $330 | $-120 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 5,830 | 4,480 | 17,680 | 0 | 0 |
| Financing Cash Flow | $5,830 | $4,480 | $17,680 | $N/A | $N/A |
| Beginning Cash Position | 3,040 | 3,870 | 2,450 | N/A | N/A |
| End Cash Position | 850 | 3,040 | 3,870 | N/A | N/A |
| Net Cash Flow | $-2,180 | $-830 | $1,410 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,060 | -5,640 | -16,140 | N/A | N/A |
| Free Cash Flow | -8,060 | -5,640 | -16,140 | 0 | 0 |